Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease - Krishnagopal Srikanth; V Sridhanya (Indian Journal of Ophthalmology)